Mid-March presentations of trial results are imminent. Price targets between $30 and $34 have been set. Today, RSI is testing a level that has recently held.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
